Lotus Bio-Technology Development Corp
OTC:LBTD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Lotus Bio-Technology Development Corp
Short-Term Debt
Lotus Bio-Technology Development Corp
Short-Term Debt Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Short-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
L
|
Lotus Bio-Technology Development Corp
OTC:LBTD
|
Short-Term Debt
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Alibaba Pictures Group Ltd
HKEX:1060
|
Short-Term Debt
¥340.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
94%
|
CAGR 10-Years
N/A
|
|
|
C
|
China Star Entertainment Ltd
HKEX:326
|
Short-Term Debt
HK$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Huanxi Media Group Ltd
HKEX:1003
|
Short-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Starlight Culture Entertainment Group Ltd
HKEX:1159
|
Short-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Global Digital Creations Holdings Ltd
HKEX:8271
|
Short-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Lotus Bio-Technology Development Corp
Glance View
Lotus Bio-Technology Development Corp. refines organic materials to produce natural consumer products. The firm focuses on specializing in the refining of organic materials and the production of natural consumer related products. The company is exploring opportunities in the organic growth and farming sector in China. The firm's operations are organizational matters, planning its Websites and developing its business plan. The firm is in start-up stage and has not generated any revenues.
See Also
What is Lotus Bio-Technology Development Corp's Short-Term Debt?
Short-Term Debt
0
USD
Based on the financial report for Dec 31, 2017, Lotus Bio-Technology Development Corp's Short-Term Debt amounts to 0 USD.